Exclusive: J&J attracts Chinese interest for diabetes business in potential $3-4 billion deal – sources

HONG KONG (Reuters) – Chinese bidders are circling a diabetes care business owned by the world’s largest healthcare company Johnson & Johnson in a deal that could fetch up to $4 billion, five people with direct knowledge told Reuters.

Powered by WPeMatico

Scroll to top